RHO (Rhodopsin) variants and mutations
RHO (also known as Rhodopsin) is a human protein-coding gene encoding a rhodopsin protein. Photon absorption converts its retinal chromophore and triggers the G-protein cascade that initiates rod phototransduction. Pathogenic variants are a major cause of autosomal dominant retinitis pigmentosa and can also cause congenital stationary night blindness. This analysis covers 839 RHO variants and mutations. Of these, 85% have computational variant effect predictions. Disease context includes insomnia, prostate carcinoma, and hypersomnia. Example RHO variants include M1V, N2S, and N2D.
Variant analysis overview
- Gene: RHO
- Protein: Rhodopsin
- UniProt accession: P08100
- Organism: Homo sapiens
- Variants analyzed: 839
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 588 unspecified-consequence records; 84 missense variants; 135 synonymous variants; 5 stop-gained variants; 15 frameshift variants; 5 splice-region variants; 2 in-frame deletions; 5 substitution
- Prediction scores: 712 variants have prediction scores (85% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: insomnia, prostate carcinoma, hypersomnia, breast cancer, breast carcinoma, acute myeloid leukemia, melanoma, neoplasm, gastric cancer, COVID-19, cancer, colon sessile serrated adenoma/polyp.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 2 binding sites; 10 post-translational modification sites.
- Structural context: 356 variants have structural context.
- PTM context: 18 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable RHO variants
Examples include M1V, N2S, N2D, G3D, G3G, T4A, T4K, E5*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs1426348071, ClinGen CA354494988, ClinVar RCV003670865, MetaLR 0.31, MetaSVM -0.40, Uncertain significance, not provided
- N2S (p.Asn2Ser), gnomAD rs2084755497, REVEL 0.74, CADD 23.30
- N2D (p.Asn2Asp), gnomAD 3-129528737-A-G, REVEL 0.76, CADD 25.50
- G3D (p.Gly3Asp), rs972605266, ClinGen CA82646516, ClinVar RCV001994148, gnomAD rs972605266, AlphaMissense 0.61, MetaLR 0.98, Uncertain significance, not provided
- G3G (p.Gly3Gly), rs2108749120, gnomAD 3-129528742-C-T, CADD 7.20
- T4A (p.Thr4Ala), TOPMed rs2084755534, REVEL 0.80, CADD 24.80
- T4K (p.Thr4Lys), rs2533019344, ClinGen CA354495098, ClinVar RCV003890822, UniProt VAR 004765, Uncertain significance, Retinal dystrophy
- E5* (p.Glu5Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E5G (p.Glu5Gly), rs144270441, ClinGen CA2607036, ClinVar RCV001316648, ESP rs144270441, REVEL 0.93, CADD 27.20, Uncertain significance, not provided
- G6D (p.Gly6Asp), Ensembl rs919315991
- G6S (p.Gly6Ser), rs145024369, ClinGen CA2607037, ClinVar RCV001075304, ClinVar RCV005093415, AlphaMissense 0.66, MetaLR 0.98, Uncertain significance, Retinal dystrophy; not provided
- G6G (p.Gly6Gly), rs768787274, gnomAD 3-129528751-C-T, CADD 10.10
- P7L (p.Pro7Leu), gnomAD rs1312492810, REVEL 0.35, CADD 16.70
- F9L (p.Phe9Leu), rs1361105199, ClinGen CA354495202, ClinVar RCV001322759, TOPMed rs1361105199, REVEL 0.85, CADD 24.30, Uncertain significance, not provided
- F9V (p.Phe9Val), rs2108749130, ClinGen CA354495193, ClinVar RCV001897851, Ensembl rs2108749130, AlphaMissense 0.71, MetaLR 0.97, Uncertain significance, not provided
- F9F (p.Phe9Phe), rs1361105199, gnomAD 3-129528760-C-T, CADD 11.20
- Y10* (p.Tyr10Ter), 1000Genomes rs138142023, ESP rs138142023, ExAC rs138142023, TOPMed rs138142023, CADD 33.00, Benign
- Y10F (p.Tyr10Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y10Y (p.Tyr10Tyr), rs138142023, gnomAD 3-129528763-C-T, CADD 6.07
- V11M (p.Val11Met), rs1251088622, ClinGen CA354495245, NCI-TCGA Cosmic COSV5621, NCI-TCGA Cosmic COSV9996, REVEL 0.53, CADD 23.20, Uncertain significance, not provided; Retinal dystrophy
- V11L (p.Val11Leu), gnomAD 3-129528764-G-T, REVEL 0.43, CADD 14.70
- V11A (p.Val11Ala), gnomAD 3-129528765-T-C, REVEL 0.69, CADD 25.40
- V11V (p.Val11Val), rs767363145, gnomAD 3-129528766-G-C, CADD 6.85
- P12L (p.Pro12Leu), gnomAD rs1198077854, REVEL 0.98, AlphaMissense 0.70, Uncertain significance
- P12R (p.Pro12Arg), rs1198077854, ClinGen CA354495267, ClinVar RCV001339625, gnomAD rs1198077854, AlphaMissense 0.70, MetaLR 0.98, Uncertain significance, not provided
- P12T (p.Pro12Thr), ExAC rs773022490, gnomAD rs773022490, REVEL 0.94, CADD 24.60
- P12A (p.Pro12Ala), gnomAD 3-129528767-C-G, REVEL 0.95, CADD 24.30
- P12P (p.Pro12Pro), rs1239256015, gnomAD 3-129528769-C-T, CADD 11.70
- F13L (p.Phe13Leu), NCI-TCGA TCGA novel, REVEL 0.30, CADD 21.30, Variant assessed as somatic; moderate impact.
- F13S (p.Phe13Ser), rs2533019429, ClinGen CA354495292, ClinVar RCV003890823, Uncertain significance, Retinal dystrophy
- F13F (p.Phe13Phe), gnomAD 3-129528772-C-T, CADD 10.90
- S14F (p.Ser14Phe), gnomAD 3-129528774-C-T, REVEL 0.79, CADD 25.70
- S14S (p.Ser14Ser), rs1456787939, gnomAD 3-129528775-C-T, CADD 11.00
- N15D (p.Asn15Asp), rs2533019441, ClinGen CA354495323, ClinVar RCV003035788, Uncertain significance, not provided
- N15I (p.Asn15Ile), rs104893786, ClinGen CA354495329, ClinVar RCV001093177, Ensembl rs104893786, AlphaMissense 0.29, MetaLR 0.96, Likely pathogenic, not provided
- N15K (p.Asn15Lys), rs1578278088, ClinGen CA354495336, ClinVar RCV001379130, Ensembl rs1578278088, AlphaMissense 0.87, MetaLR 0.94, Likely pathogenic, not provided; Retinitis pigmentosa 4
- N15S (p.Asn15Ser), rs104893786, ClinGen CA256685, ClinVar RCV000013917, ClinVar RCV000132598, REVEL 0.79, AlphaMissense 0.29, Pathogenic/Likely pathogenic, Retinal dystrophy; not provided; Retinitis pigmentosa 4
- A16V (p.Ala16Val), rs201340914, ClinGen CA2607043, NCI-TCGA Cosmic COSV5621, ClinVar RCV001055757, REVEL 0.14, CADD 12.80, Uncertain significance, not provided
- A16T (p.Ala16Thr), gnomAD 3-129528779-G-A, REVEL 0.16, CADD 9.71
- A16E (p.Ala16Glu), gnomAD 3-129528780-C-A, REVEL 0.15, CADD 8.05
- A16A (p.Ala16Ala), rs766112074, gnomAD 3-129528781-G-A, CADD 7.50
- T17A (p.Thr17Ala), gnomAD rs1387357649, REVEL 0.32, CADD 22.40
- T17K (p.Thr17Lys), rs104893769, ClinGen CA354495380, ClinVar RCV001265170, ClinVar RCV001305331, AlphaMissense 0.62, MetaLR 0.33, Likely pathogenic, not provided; Retinitis pigmentosa 4
- T17M (p.Thr17Met), rs104893769, ClinGen CA256665, NCI-TCGA Cosmic COSV5621, ClinVar RCV000013892, REVEL 0.49, AlphaMissense 0.62, Pathogenic, Retinal dystrophy; not specified; not provided
- T17T (p.Thr17Thr), rs753585848, gnomAD 3-129528784-G-A, CADD 3.00
- G18A (p.Gly18Ala), rs200946638, ClinGen CA2607048, ClinVar RCV002672089, ExAC rs200946638, REVEL 0.90, AlphaMissense 0.53, Uncertain significance, not provided
- G18D (p.Gly18Asp), rs200946638, ClinGen CA2607047, ClinVar RCV000767356, ClinVar RCV001003166, REVEL 0.92, AlphaMissense 0.53, Conflicting interpretations, not provided; Retinitis pigmentosa 4
- G18S (p.Gly18Ser), Ensembl rs2108749149, REVEL 0.81, CADD 24.50
- G18V (p.Gly18Val), rs200946638, ClinGen CA354495405, ClinVar RCV001903209, ExAC rs200946638, AlphaMissense 0.53, MetaLR 0.98, Uncertain significance, not provided
- G18C (p.Gly18Cys), gnomAD 3-129528785-G-T, REVEL 0.95, CADD 28.10
- G18G (p.Gly18Gly), rs1578278108, gnomAD 3-129528787-T-G, CADD 3.99
- V19M (p.Val19Met), TOPMed rs1372284722, gnomAD rs1372284722, REVEL 0.52, CADD 19.80
- V19V (p.Val19Val), rs757740913, gnomAD 3-129528790-G-A, CADD 8.85
- V20A (p.Val20Ala), ExAC rs746210043, TOPMed rs746210043, gnomAD rs746210043, REVEL 0.75, CADD 24.40
- V20I (p.Val20Ile), rs370401948, ClinGen CA2607050, ClinVar RCV001073770, ClinVar RCV001862809, REVEL 0.67, AlphaMissense 0.20, Uncertain significance, not provided; Retinal dystrophy
- V20L (p.Val20Leu), rs370401948, ClinGen CA354495445, ClinVar RCV002865998, AlphaMissense 0.20, MetaLR 0.93, Uncertain significance, not provided
- V20V (p.Val20Val), rs1560045604, gnomAD 3-129528793-A-G, CADD 8.13
- R21C (p.Arg21Cys), TOPMed rs1451320951, gnomAD rs1451320951, REVEL 0.95, CADD 26.70, Uncertain significance, Retinitis pigmentosa 4
- R21H (p.Arg21His), rs552455660, ClinGen CA2607052, ClinVar RCV001145548, ClinVar RCV001145549, REVEL 0.88, AlphaMissense 0.41, Conflicting interpretations, not provided; Retinitis pigmentosa; Congenital stationary night blindness autoso
- R21P (p.Arg21Pro), rs552455660, ClinGen CA354495457, ClinVar RCV002843392, AlphaMissense 0.41, MetaLR 0.98, Uncertain significance, not provided
- R21L (p.Arg21Leu), gnomAD 3-129528795-G-T, REVEL 0.88, CADD 27.30
- R21R (p.Arg21Arg), gnomAD 3-129528796-C-T, CADD 11.00
- S22N (p.Ser22Asn), ESP rs376111618, ExAC rs376111618, TOPMed rs376111618, gnomAD rs376111618, REVEL 0.43, CADD 21.90
- S22R (p.Ser22Arg), rs749567084, ClinGen CA354495476, ClinVar RCV001265171, ExAC rs749567084, AlphaMissense 0.92, MetaLR 0.89, Uncertain significance, Retinitis pigmentosa 4
- S22S (p.Ser22Ser), rs749567084, gnomAD 3-129528799-C-T, AlphaMissense 0.92, MetaLR 0.89
- P23A (p.Pro23Ala), rs104893797, ClinGen CA256695, ClinVar RCV000013930, Ensembl rs104893797, AlphaMissense 0.56, MetaLR 0.99, Pathogenic, Retinitis pigmentosa 4
- P23H (p.Pro23His), rs104893768, ClinGen CA256661, ClinVar RCV000013887, ClinVar RCV000490234, REVEL 0.98, AlphaMissense 0.92, Pathogenic, Retinal dystrophy; Retinitis pigmentosa 4; Pigmentary retinal dystrophy
- P23L (p.Pro23Leu), rs104893768, ClinGen CA354495503, ClinVar RCV001384458, ClinVar RCV003888084, AlphaMissense 0.92, MetaLR 0.99, Pathogenic/Likely pathogenic, Retinal dystrophy; not provided
- P23S (p.Pro23Ser), rs104893797, ClinGen CA354495494, ClinVar RCV001262654, Ensembl rs104893797, AlphaMissense 0.56, MetaLR 0.99, Likely pathogenic, Retinitis pigmentosa 4
- P23T (p.Pro23Thr), rs104893797, ClinGen CA354495488, ClinVar RCV003883226, AlphaMissense 0.56, MetaLR 0.99, Likely pathogenic, Retinitis pigmentosa 4
- F24C (p.Phe24Cys), rs2533019513, ClinGen CA354495513, ClinVar RCV002807022, Uncertain significance, not provided
- F24L (p.Phe24Leu), rs768877243, ClinGen CA354495523, ClinVar RCV001073462, ExAC rs768877243, REVEL 0.83, CADD 21.60, Uncertain significance, Retinal dystrophy
- F24S (p.Phe24Ser), rs2533019513, ClinGen CA354495517, ClinVar RCV003564497, ClinVar RCV004818383, Uncertain significance, not provided
- F24F (p.Phe24Phe), rs768877243, gnomAD 3-129528805-C-T, CADD 9.57
- E25D (p.Glu25Asp), ExAC rs748211662, TOPMed rs748211662, gnomAD rs748211662, REVEL 0.11, CADD 20.20
- E25K (p.Glu25Lys), rs774425557, ClinGen CA2607056, NCI-TCGA Cosmic COSV5621, NCI-TCGA Cosmic COSV9996, REVEL 0.49, AlphaMissense 0.45, Uncertain significance, not provided
- E25Q (p.Glu25Gln), rs774425557, NCI-TCGA Cosmic COSV5621, NCI-TCGA Cosmic COSV9996, ExAC rs774425557, AlphaMissense 0.45, MetaLR 0.20, Uncertain significance
- E25A (p.Glu25Ala), gnomAD 3-129528807-A-C, REVEL 0.41, CADD 26.00
- E25E (p.Glu25Glu), rs748211662, gnomAD 3-129528808-G-A, CADD 9.75
- Y26* (p.Tyr26Ter), gnomAD rs966749682
- Y26C (p.Tyr26Cys), gnomAD rs1309373132, REVEL 0.73, CADD 18.10
- Y26H (p.Tyr26His), Ensembl rs2108749173
- P27S (p.Pro27Ser), TOPMed rs560600890, gnomAD rs560600890, REVEL 0.92, CADD 25.10
- P27T (p.Pro27Thr), TOPMed rs560600890, gnomAD rs560600890, REVEL 0.93, CADD 24.80
- Q28E (p.Gln28Glu), rs2108749182, ClinGen CA354495577, ClinVar RCV003890824, AlphaMissense 0.70, MetaLR 0.97, Uncertain significance, Retinal dystrophy
- Q28H (p.Gln28His), rs2108749184, ClinGen CA354495588, ClinVar RCV001699940, UniProt VAR 004770, AlphaMissense 0.90, MetaLR 0.97, Pathogenic, Retinitis pigmentosa 4
- Q28K (p.Gln28Lys), rs2108749182, ClinGen CA354495572, ClinVar RCV001928742, Ensembl rs2108749182, REVEL 0.95, AlphaMissense 0.70, Uncertain significance, not provided
- Q28R (p.Gln28Arg), rs1553780837, ClinGen CA354495583, ClinVar RCV000505117, ClinVar RCV001296378, AlphaMissense 0.65, MetaLR 0.97, Pathogenic, Retinal dystrophy; not provided
- Q28* (p.Gln28Ter), gnomAD 3-129528815-C-T, CADD 36.00
- Y29C (p.Tyr29Cys), rs2084756646, ClinGen CA354495615, ClinVar RCV001227379, Ensembl rs2084756646, AlphaMissense 0.88, MetaLR 0.97, Uncertain significance, not provided
- Y29H (p.Tyr29His), gnomAD rs1323411269, REVEL 0.84, CADD 27.30
- Y29Y (p.Tyr29Tyr), rs149084537, gnomAD 3-129528820-C-T, CADD 8.91
- Y30* (p.Tyr30Ter), TOPMed rs1245030121, gnomAD rs1245030121, CADD 36.00
- Y30Y (p.Tyr30Tyr), rs1245030121, gnomAD 3-129528823-C-T, CADD 8.81
- L31P (p.Leu31Pro), rs2533019562, ClinGen CA354495650, ClinVar RCV003699442, Uncertain significance, not provided
- L31V (p.Leu31Val), ExAC rs773077062, gnomAD rs773077062, REVEL 0.82, CADD 23.80
- L31L (p.Leu31Leu), rs773077062, gnomAD 3-129528824-C-T, CADD 9.61
- A32P (p.Ala32Pro), rs2084756721, ClinGen CA354495674, ClinVar RCV001075054, Ensembl rs2084756721, AlphaMissense 0.93, MetaLR 0.95, Uncertain significance, Retinal dystrophy
- A32S (p.Ala32Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A32A (p.Ala32Ala), rs2084756732, gnomAD 3-129528829-T-C, CADD 0.55
- E33D (p.Glu33Asp), rs1232548343, ClinGen CA354495705, ClinVar RCV003046374, gnomAD rs1232548343, REVEL 0.16, CADD 17.40, Uncertain significance, not provided
- E33K (p.Glu33Lys), NCI-TCGA Cosmic COSV9907, NCI-TCGA Cosmic COSV9996, REVEL 0.61, CADD 23.10, Variant assessed as somatic; moderate impact.
- E33E (p.Glu33Glu), rs1232548343, gnomAD 3-129528832-G-A, CADD 9.08
- P34L (p.Pro34Leu), rs2108749194, ClinGen CA354495719, ClinVar RCV001360203, Ensembl rs2108749194, REVEL 0.90, CADD 24.20, Uncertain significance, not provided
- P34S (p.Pro34Ser), gnomAD 3-129528833-C-T, REVEL 0.85, CADD 23.60
- P34P (p.Pro34Pro), rs1186151173, gnomAD 3-129528835-A-G, CADD 2.08
- W35* (p.Trp35Ter), rs771123958, NCI-TCGA Cosmic COSV9996, Ensembl rs771123958, Variant assessed as somatic; high impact.
- W35R (p.Trp35Arg), rs1259844494, ClinGen CA354495726, ClinVar RCV001979172, TOPMed rs1259844494, REVEL 0.88, CADD 25.20, Uncertain significance, not provided
- Q36* (p.Gln36Ter), rs760515764, ClinGen CA354495749, ClinVar RCV002000157, ExAC rs760515764, AlphaMissense 0.23, MetaLR 0.05, Pathogenic
- Q36H (p.Gln36His), ExAC rs766344345, gnomAD rs766344345, REVEL 0.18, CADD 22.50
- Q36K (p.Gln36Lys), ExAC rs760515764, gnomAD rs760515764, REVEL 0.06, AlphaMissense 0.23, Pathogenic
- Q36R (p.Gln36Arg), Ensembl rs755171690, REVEL 0.17, CADD 22.00
- Q36L (p.Gln36Leu), gnomAD 3-129528840-A-T, REVEL 0.14, CADD 22.30
- F37L (p.Phe37Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S38P (p.Ser38Pro), gnomAD 3-129528845-T-C, REVEL 0.19, CADD 24.50
- S38C (p.Ser38Cys), gnomAD 3-129528846-C-G, REVEL 0.34, CADD 23.80
- S38S (p.Ser38Ser), rs2084756872, gnomAD 3-129528847-C-A, CADD 9.21
- M39L (p.Met39Leu), ExAC rs776411064, TOPMed rs776411064, gnomAD rs776411064, REVEL 0.12, AlphaMissense 0.07
- M39R (p.Met39Arg), rs2084756915, ClinGen CA354495787, ClinVar RCV001265172, ClinVar RCV001384459, REVEL 0.23, CADD 20.70, Pathogenic/Likely pathogenic, Retinitis pigmentosa 4; not provided; Retinal disorder
- M39V (p.Met39Val), rs776411064, ClinGen CA354495783, ClinVar RCV003014929, AlphaMissense 0.07, MetaLR 0.01, Uncertain significance, not provided
- L40R (p.Leu40Arg), UniProt VAR 004771, Pathogenic, in RP4
- L40V (p.Leu40Val), gnomAD 3-129528851-C-G, REVEL 0.18, CADD 22.90
- L40L (p.Leu40Leu), rs759209103, gnomAD 3-129528851-C-T, CADD 10.40
- A41T (p.Ala41Thr), rs927794488, ClinGen CA82646751, ClinVar RCV003722060, TOPMed rs927794488, REVEL 0.32, CADD 22.50, Uncertain significance, not provided
- A41A (p.Ala41Ala), rs781550757, gnomAD 3-129528856-C-T, CADD 6.82
- A42T (p.Ala42Thr), rs538820015, ClinGen CA2607065, ClinVar RCV001897809, ClinVar RCV003888375, REVEL 0.28, CADD 26.00, Conflicting interpretations, Retinal dystrophy; not provided
- A42V (p.Ala42Val), gnomAD 3-129528858-C-T, REVEL 0.24, CADD 23.50
- Y43C (p.Tyr43Cys), rs748429090, ClinGen CA2607066, ClinVar RCV003818353, ExAC rs748429090, REVEL 0.53, CADD 26.00, Uncertain significance, not provided
- Y43Y (p.Tyr43Tyr), gnomAD 3-129528862-C-T, CADD 8.65
- M44I (p.Met44Ile), TOPMed rs1289938976, gnomAD rs1289938976, REVEL 0.41, CADD 24.00
- M44L (p.Met44Leu), rs1287941897, ClinGen CA354495864, ClinVar RCV002756596, gnomAD rs1287941897, REVEL 0.42, CADD 25.10, Uncertain significance, not provided
- M44T (p.Met44Thr), rs774336493, ClinGen CA2607067, ClinVar RCV002026974, UniProt VAR 004772, REVEL 0.74, CADD 25.40, Likely pathogenic, not provided
- M44V (p.Met44Val), gnomAD rs1287941897, REVEL 0.46, CADD 24.70, Uncertain significance, Retinal dystrophy
- F45L (p.Phe45Leu), rs104893770, ClinGen CA256666, ClinVar RCV000013893, ClinVar RCV001851838, REVEL 0.20, CADD 23.60, Uncertain significance, not provided
- L46R (p.Leu46Arg), rs2084757073, ClinGen CA354495905, ClinVar RCV001090661, UniProt VAR 004774, AlphaMissense 0.97, MetaLR 0.21, Pathogenic, not provided
- L46L (p.Leu46Leu), gnomAD 3-129528871-G-A, CADD 8.96
- L47L (p.Leu47Leu), rs1257389194, gnomAD 3-129528872-C-T, CADD 9.37
- I48M (p.Ile48Met), gnomAD 3-129528877-C-G, REVEL 0.32, CADD 16.20
- I48I (p.Ile48Ile), gnomAD 3-129528877-C-A, CADD 3.90
- V49M (p.Val49Met), rs534819675, ClinGen CA2607069, ClinVar RCV001932362, 1000Genomes rs534819675, REVEL 0.05, CADD 15.80, Uncertain significance, not provided
- L50P (p.Leu50Pro), Ensembl rs2084757134
- L50L (p.Leu50Leu), gnomAD 3-129528881-C-T, CADD 9.00
- G51A (p.Gly51Ala), rs149079952, ClinGen CA2607070, ClinVar RCV000279557, ClinVar RCV000336890, REVEL 0.43, CADD 23.30, Benign/Likely benign, Congenital stationary night blindness autosomal dominant 1; not provided; Retini
- G51C (p.Gly51Cys), Ensembl rs104893792, Pathogenic, in RP4
- G51R (p.Gly51Arg), rs104893792, ClinGen CA256687, ClinVar RCV000013922, ClinVar RCV001237838, REVEL 0.52, CADD 26.60, Pathogenic, RHO-related disorder; not provided
- G51V (p.Gly51Val), rs149079952, ClinGen CA354495947, ClinVar RCV001074351, ClinVar RCV002557910, REVEL 0.55, CADD 25.00, Pathogenic, not provided; Retinal dystrophy
- G51G (p.Gly51Gly), gnomAD 3-129528886-C-T, CADD 9.69
- F52L (p.Phe52Leu), Ensembl rs926235922
- F52Y (p.Phe52Tyr), gnomAD 3-129528888-T-A, REVEL 0.42, CADD 23.80
- P53R (p.Pro53Arg), rs28933395, ClinGen CA256682, ClinVar RCV000013912, ClinVar RCV000504903, AlphaMissense 0.99, MetaLR 0.34, Pathogenic, not provided; Retinitis pigmentosa 4
- P53L (p.Pro53Leu), gnomAD 3-129528891-C-T, REVEL 0.53, CADD 25.70
- I54V (p.Ile54Val), ExAC rs755190538, gnomAD rs755190538, REVEL 0.06, CADD 16.90
- N55K (p.Asn55Lys), rs1312862210, ClinGen CA354495999, ClinVar RCV001265173, ClinVar RCV001880087, REVEL 0.88, CADD 24.90, Pathogenic, not provided; Retinitis pigmentosa 4
- N55D (p.Asn55Asp), gnomAD 3-129528896-A-G, REVEL 0.94, CADD 26.80
- N55S (p.Asn55Ser), gnomAD 3-129528897-A-G, REVEL 0.93, CADD 25.50
- N55N (p.Asn55Asn), rs1312862210, gnomAD 3-129528898-C-T, CADD 9.87
- L57F (p.Leu57Phe), Ensembl rs2108749232
- L57L (p.Leu57Leu), rs779029199, gnomAD 3-129528904-C-T, CADD 9.43
- T58* (p.Thr58Ter), rs2084757329, ClinGen CA916082603, ClinVar RCV001075164, ClinVar RCV003718311, Pathogenic, in RP4
- T58M (p.Thr58Met), rs28933394, ClinGen CA2607073, ClinVar RCV001242415, ClinVar RCV001265174, REVEL 0.74, CADD 25.40, Uncertain significance, Microcephaly 17, primary, autosomal recessive; Occult macular dystrophy; not pro
- T58R (p.Thr58Arg), rs28933394, ClinGen CA256664, ClinVar RCV000013890, ClinVar RCV001074373, REVEL 0.82, CADD 25.10, Pathogenic/Likely pathogenic, Retinal dystrophy; not provided; Retinitis pigmentosa 4
- T58K (p.Thr58Lys), gnomAD 3-129528906-C-A, REVEL 0.80, CADD 25.40
- T58T (p.Thr58Thr), rs112640710, gnomAD 3-129528907-G-A, CADD 7.42
- L59F (p.Leu59Phe), rs777849735, ClinGen CA2607075, ClinVar RCV002003246, ExAC rs777849735, REVEL 0.75, CADD 25.00, Uncertain significance, not provided
- L59H (p.Leu59His), rs2108749238, ClinGen CA354496057, ClinVar RCV001969487, Ensembl rs2108749238, AlphaMissense 1.00, MetaLR 0.74, Pathogenic, not provided
- L59I (p.Leu59Ile), ExAC rs777849735, TOPMed rs777849735, gnomAD rs777849735, Uncertain significance
- L59R (p.Leu59Arg), rs2108749238, ClinGen CA354496062, ClinVar RCV001754606, Ensembl rs2108749238, AlphaMissense 1.00, MetaLR 0.74, Uncertain significance, not provided
- L59L (p.Leu59Leu), rs747002188, gnomAD 3-129528910-C-G, CADD 8.00
- Y60* (p.Tyr60Ter), rs527236101, ClinGen CA354496086, ClinVar RCV001382599, TOPMed rs527236101, CADD 33.00, Pathogenic
- Y60H (p.Tyr60His), rs771007146, ClinGen CA2607077, ClinVar RCV000767357, ClinVar RCV002533923, REVEL 0.31, CADD 24.30, Uncertain significance, not provided
- Y60Y (p.Tyr60Tyr), rs527236101, gnomAD 3-129528913-C-T, CADD 3.84
- V61A (p.Val61Ala), gnomAD rs1427114435, REVEL 0.50, CADD 24.50
- V61I (p.Val61Ile), ExAC rs776504351, TOPMed rs776504351, gnomAD rs776504351, REVEL 0.49, CADD 25.90, Uncertain significance, not provided
- T62A (p.Thr62Ala), ExAC rs759425622, gnomAD rs759425622, REVEL 0.65, CADD 25.90
- T62N (p.Thr62Asn), rs769464362, ClinGen CA2607080, ClinVar RCV000767358, ClinVar RCV001869053, REVEL 0.60, CADD 24.60, Uncertain significance, not provided
- T62T (p.Thr62Thr), rs367909246, gnomAD 3-129528919-C-G, CADD 2.87
- V63I (p.Val63Ile), rs146936681, ClinGen CA2607082, ClinVar RCV001364807, 1000Genomes rs146936681, REVEL 0.06, CADD 15.10, Uncertain significance, not provided
- V63R (p.Val63Arg), rs2084757540, gnomAD 3-129528917-A-AC, CADD 28.20
- Q64* (p.Gln64Ter), rs2084757596, ClinGen CA354496130, ClinVar RCV001241342, Ensembl rs2084757596, Pathogenic
- Q64P (p.Gln64Pro), gnomAD 3-129528924-A-C, REVEL 0.58, CADD 26.80
Public RHO analysis runs
- RHO analysis run — RHO (839 variants) — completed 2026-08-18